OBJECTIVES: The purpose of this study was to identify the type and frequency of drug-related problems (DRPs) that are encountered when dispensing secondary care prescriptions in community pharmacy. METHODS: A cross-sectional study was conducted attempting to recruit all patients presenting with secondary care prescriptions to a single community pharmacy in New Zealand over a 3-month period. The DRPs were recorded to allow analysis of the types and frequencies of the problems seen. KEY FINDINGS: During the 3-month period 401 patients consented to participate and 840 prescription items were analysed. DRPs were identified in 20% of prescription items analysed (n = 172), affecting 38% patients (n = 155). Bureaucratic interventions concerning product availability and payment issues accounted for 55% and affected 11% of the prescription items analysed. The remaining 45% of DRPs concerned clinical and patient issues and affected 9% of prescription items. CONCLUSIONS: This study has shown that the secondary-primary interface is problematic with respect to DRPs. Although pharmacists are in a position to identify and act on these DRPs, access to basic patient notes such as a discharge summary and including pharmacists in the communication between secondary and primary providers should assist in achieving seamless care for the patient and help to identify and prevent DRPs.
OBJECTIVES: The purpose of this study was to identify the type and frequency of drug-related problems (DRPs) that are encountered when dispensing secondary care prescriptions in community pharmacy. METHODS: A cross-sectional study was conducted attempting to recruit all patients presenting with secondary care prescriptions to a single community pharmacy in New Zealand over a 3-month period. The DRPs were recorded to allow analysis of the types and frequencies of the problems seen. KEY FINDINGS: During the 3-month period 401 patients consented to participate and 840 prescription items were analysed. DRPs were identified in 20% of prescription items analysed (n = 172), affecting 38% patients (n = 155). Bureaucratic interventions concerning product availability and payment issues accounted for 55% and affected 11% of the prescription items analysed. The remaining 45% of DRPs concerned clinical and patient issues and affected 9% of prescription items. CONCLUSIONS: This study has shown that the secondary-primary interface is problematic with respect to DRPs. Although pharmacists are in a position to identify and act on these DRPs, access to basic patient notes such as a discharge summary and including pharmacists in the communication between secondary and primary providers should assist in achieving seamless care for the patient and help to identify and prevent DRPs.
Authors: Rhiannon Braund; Carolyn V Coulter; Amy Jane Bodington; Lauren Margaret Giles; Anna-Marie Greig; Larissa Jane Heaslip; Brooke Jane Marshall Journal: Int J Clin Pharm Date: 2014-04-04
Authors: Maria Dobrinas-Bonazzi; Nicolas Widmer; Sophie Grandchamp; Anne-Laure Blanc; Marine Roussel; Damien Tagan; Annelore Sautebin Journal: Drugs Real World Outcomes Date: 2021-12-31
Authors: Laura V J Lech; Gitte R Husted; Anna Birna Almarsdottír; Trine R H Andersen; Charlotte Rossing; Lotte S Nørgaard Journal: Innov Pharm Date: 2020-07-31
Authors: Beth Fylan; Hanif Ismail; Suzanne Hartley; Chris P Gale; Amanda J Farrin; Peter Gardner; Jonathan Silcock; David P Alldred Journal: Pilot Feasibility Stud Date: 2021-03-26